Clinical Trial Update: Uproleselan With Pre-Transplant Conditioning in Hematopoietic Stem Cell Transplantation for AML [Phase 1]

View source ↗

Summary

Phase 1 trial of uproleselan with pre-transplant conditioning in hematopoietic stem cell transplantation for acute myeloid leukemia has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Uproleselan (uproleselan)

Snippet

Sponsor: Malika Kapadia | Conditions: Acute Myeloid Leukemia, Pediatric Cancer | Phase 1 | Status: TERMINATED